COMMUNIQUÉS West-GlobeNewswire

AgraFlora Organics Welcomes Collection of Industry Analysts, Institutional Investors and Media Personnel to June 25th Delta Greenhouse Tour; Broadcast To Be Made Available Online Via Corporate Website
20/06/2019
VANCOUVER, British Columbia, June 20, 2019 (GLOBE NEWSWIRE) -- AgraFlora Organics International Inc. (“ AgraFlora ” or the “ Company ”) ( CSE: AGRA) (Frankfurt: PU31) (OTCPK: PUFXF ), a growth oriented and diversified [...]
Innate Pharma to host key opinion leader call on IPH4102 “TELLOMAK” clinical trial design and rationale
20/06/2019
INNATE PHARMA TO HOST KEY OPINION LEADER CALL ON IPH4102 “TELLOMAK” CLINICAL TRIAL DESIGN AND RATIONALE Marseille, France, June 20, 2019, 07:00 AM CEST Innate Pharma SA (the “Company” - Euronext Paris: FR0010331421 – [...]
Innate Pharma organise une conférence téléphonique avec un expert sur le rationnel et le design de l’essai « TELLOMAK » d’IPH4102
20/06/2019
INNATE PHARMA ORGANISE UNE CONFÉRENCE TÉLÉPHONIQUE AVEC UN EXPERT SUR LE RATIONNEL ET LE DESIGN DE L’ESSAI « TELLOMAK » D’IPH4102 Marseille, 20 juin 2019, 07h00 Innate Pharma SA (la « Société » - Euronext Paris : [...]
Addex Shareholders Approve All Resolutions at Annual General Meeting
20/06/2019
Geneva, Switzerland, 20 June 2019 – Addex Therapeutics (SIX: ADXN), a leading company pioneering allosteric modulation-based drug discovery and development, announced today that its shareholders approved with a very [...]
Genocea Announces Pricing of $36,750,000 Public Offering of Common Stock
20/06/2019
CAMBRIDGE, Mass., June 19, 2019 (GLOBE NEWSWIRE) -- Genocea Biosciences, Inc . (NASDAQ: GNCA), a biopharmaceutical company developing personalized cancer immunotherapies, today announced the pricing of its previously [...]
Atreca Announces Pricing of Initial Public Offering
20/06/2019
REDWOOD CITY, Calif., June 19, 2019 (GLOBE NEWSWIRE) -- Atreca, Inc. (Nasdaq: BCEL), a biopharmaceutical company utilizing its differentiated platform to discover and develop novel antibody-based immunotherapeutics to [...]
Cronos Group Inc. Announces Results of Vote for Election of Directors
20/06/2019
TORONTO, June 19, 2019 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“ Cronos Group ” or the “ Company ”) reports that at its Annual Meeting of Shareholders on June 19, 2019 there were 610 [...]
Scholar Rock Announces Pricing of Public Offering of Common Stock
20/06/2019
CAMBRIDGE, Mass., June 19, 2019 (GLOBE NEWSWIRE) -- Scholar Rock Holding Corporation (Nasdaq: SRRK), a clinical-stage biopharmaceutical company focused on the treatment of serious diseases in which protein growth [...]
North Bud Farms Closes First Tranche of Private Placement Financing
19/06/2019
Insider of NORTHBUD Invests $1 Million as Lead Order THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT INTENDED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED [...]
Optinose Named a 2019 Best Place to Work by Philadelphia Business Journal
19/06/2019
YARDLEY, Pa., June 19, 2019 (GLOBE NEWSWIRE) -- Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today announced that the Company has [...]
Sonoma Pharmaceuticals Announces 1-for-9 Reverse Split of Outstanding Common Stock
19/06/2019
Company Plans to affect a Reverse Stock Split to remain listed on the Nasdaq Capital Market PETALUMA, Calif., June 19, 2019 (GLOBE NEWSWIRE) -- Specialty pharmaceutical company Sonoma Pharmaceuticals, Inc. (Nasdaq: SNOA [...]
DiaMedica Therapeutics Announces Interim Results from Phase 1b Trial of DM199 in Chronic Kidney Disease Participants
19/06/2019
Favorable DM199 safety profile across tested doses Pharmacodynamic results helped identify dose range for Phase II studies Encouraging early signals in mechanism biomarkers (NO and PGE 2 ), Kidney function (eGFR) and [...]
Rhythm Pharmaceuticals Announces Election of Jennifer Good to its Board of Directors
19/06/2019
BOSTON, June 19, 2019 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM), a biopharmaceutical company focused on the development and commercialization of therapeutics for the treatment of rare genetic [...]
Eloxx Pharmaceuticals Announces Proposed Public Offering of Common Stock
19/06/2019
WALTHAM, Mass, June 19, 2019 (GLOBE NEWSWIRE) -- Eloxx Pharmaceuticals, Inc. (“Eloxx”) (Nasdaq: ELOX) today announced that it intends to offer and sell shares of its common stock in an underwritten public offering, [...]
Precision Optics Corporation, Inc. Announces the Passing of Dr. Kenneth Schwartz
19/06/2019
GARDNER, Mass., June 19, 2019 (GLOBE NEWSWIRE) -- Precision Optics Corporation, Inc. (OTCQB: PEYE) (the “Company”) announced today that Dr. Kenneth Schwartz passed away on June 13, 2019. Dr. Schwartz was a valued member [...]
Marinus Pharmaceuticals Announces Inducement Grants Under NASDAQ Listing Rule 5635(C)(4)
19/06/2019
RADNOR, Pa., June 19, 2019 (GLOBE NEWSWIRE) -- Marinus Pharmaceuticals, Inc. (Nasdaq:MRNS) (the “Company”, “Marinus”), a biopharmaceutical company dedicated to the development of innovative therapeutics to treat [...]
Cytori Announces New Annual Stockholders Meeting Date for June 27
19/06/2019
Annual Meeting Adjourned to Provide Additional Time to Obtain Approval of Key Business SAN DIEGO, June 19, 2019 (GLOBE NEWSWIRE) -- Cytori Therapeutics, Inc. (Nasdaq: CYTX) today announced that it reconvened its annual [...]
Bavarian Nordic Initiates Phase 3 Trial of Freeze-dried MVA-BN® Smallpox Vaccine
19/06/2019
COPENHAGEN, Denmark, June 19, 2019 – Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) announced today the initiation of a pivotal Phase 3 trial of the freeze-dried formulation of MVA-BN ® smallpox vaccine in 1,110 healthy, [...]
Tauriga Sciences Inc. Constructing Point of Sale Retail Display Case to Showcase its Products
19/06/2019
New York, NY, June 19, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”), a revenue generating Company that operates through the development, distribution, [...]

Pages